Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)

Neuroendocrine

Neuroendocrine
II/III
Das, Satya
NCT05058651
SWOGGIS2012

A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer

Head/Neck

Head/Neck
II/III
Lockney, Natalie
NCT03952585
NRGHN005


Phase 3 Accelerated BEP Trial: A Randomised Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours

Germ Cell (Pediatrics)

Germ Cell (Pediatrics)
III
Borinstein, Scott
NCT02582697
COGAGCT1532

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

Multiple Cancer Types

Hepatoblastoma (Pediatrics), Pediatric Solid Tumors, Pediatrics
II/III
Benedetti, Daniel
NCT03533582
COGAHEP1531



A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Multiple Cancer Types

Germ Cell (Pediatrics), Gynecologic, Ovarian
III
Borinstein, Scott
NCT03067181
COGAGCT1531

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

Multiple Cancer Types

Neuroblastoma (Pediatrics), Pediatrics
III
Benedetti, Daniel
NCT03126916
COGANBL1531

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/PD-L1 Based Immunotherapy

Multiple Cancer Types

Bladder, Urologic
II
Davis, Nancy
NCT03547973
VICCURO18120

To learn more about any of our clinical
trials, call 615-936-8422.